Studies related to Cancer Mortality and Melatonin

Melatonin In The Treatment Of Cancer: A Systematic Review Of Randomized Controlled Trials And Meta-analysis

Effect Decrease
Trial Design Meta analysis
Trial Length n/a
Number of Subjects 643
Sex Both Genders
Notes for this study:
Supplementation of various doses of melatonin daily in cancer patients with solid tumors was able to reduce the chance of death when measured one year later, with a RR of 0.66 and 95% CI of 0.59-0.73.